Evidence map›Paper›PMID 34368905›Full record

Trial reportKnee surgery, sports traumatology, arthroscopy : official journal of the ESSKA2022

Minimal graft site morbidity using autogenous semitendinosus graft from the uninjured leg: a randomised controlled trial.

Christoffer von Essen, Sebastian McCallum, Karl Eriksson, Björn Barenius

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Christoffer von EssenDepartment of Orthopaedics, Stockholm South Hospital, Karolinska Institutet, Stockholm, Sweden. Christoffer.vonessen@gmail.com.ORCID http://orcid.org/0000-0001-6871-3267
Sebastian McCallumDepartment of Orthopaedics, Stockholm South Hospital, Karolinska Institutet, Stockholm, Sweden.
Karl ErikssonDepartment of Orthopaedics, Stockholm South Hospital, Karolinska Institutet, Stockholm, Sweden.
Björn BareniusDepartment of Orthopaedics, Stockholm South Hospital, Karolinska Institutet, Stockholm, Sweden.
Karolinska Institutet · SESophiahemmet Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo quantify the effect on strength of semitendinosus (ST) graft harvest by comparing isokinetic and isometric muscle strength.

methodsA cohort of 140 patients underwent anterior cruciate ligament (ACL) reconstruction (ACLR) and were randomized to ipsilateral or contralateral ST graft harvest. Isokinetic and isometric muscle strength testing using a dynamometer were collected for the operated and non-operated leg. Patients were assessed pre-surgery and at 6, 12 and 24 months after reconstruction.

resultsST graft harvest reduced isokinetic flexion muscle strength for 6 months. At 12 months follow up there was no significant difference between the two groups and they were all stronger than pre-injury. No other significant differences were found in any primary or secondary outcome measurements.

conclusionSolitary ST graft harvest does not appear to result in a permanent reduced isometric or isokinetic quadriceps muscle strength on the side where the graft is harvested. A reduction in hamstring muscle strength of less than 10% can be seen at short-term follow-up with full recovery by 12 months. Most patients report little or no donor site pain. Given these findings, ST autograft is an alternative graft choice that could be used for various reconstructions in terms of donor site morbidity. LEVEL OF EVIDENCE: Level II.

Indexed as

Anterior Cruciate Ligament InjuriesHamstring MusclesAutograftsHumansLegMorbidityMuscle StrengthACLACL reconstructionContralateralIsokineticSemitendinosus

Identifiers

PMID34368905
PMCPMC9033693
OpenAlexW3187347700

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.